| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 1.000 | None | 0.953 | 8 | 0 | 1987 | 2020 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.740 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
RecQ like helicase 4 | 0.496 | 0.808 | 3.3E-35 |
|
disease | 0.500 | strong | 0.833 | 1 | 0 | 2003 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.976 | 4 | 0 | 1997 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
RUNX family transcription factor 2 | 0.437 | 0.846 | 0.95 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2000 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1991 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2005 | 2020 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.390 | None | 0.900 | 1 | 0 | 2006 | 2019 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2003 | 2017 | ||||||||
|
TNF receptor superfamily member 11a | 0.480 | 0.846 | 8.8E-03 |
|
disease | 0.360 | limited | 1.000 | 2 | 0 | 2001 | 2018 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 1994 | 2018 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
nuclear receptor subfamily 1 group I member 2 | 0.418 | 0.846 | 7.3E-09 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
TOP1 binding arginine/serine rich protein | 0.659 | 0.538 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2007 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.200 | None | 0.933 | 3 | 0 | 1995 | 2019 | ||||||||
|
ezrin | 0.476 | 0.808 | 0.18 |
|
disease | 0.100 | None | 0.943 | 4 | 0 | 2003 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.889 | 4 | 0 | 1996 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 0.950 | 3 | 0 | 2005 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 0.971 | 2 | 0 | 2006 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.100 | None | 0.895 | 2 | 0 | 1998 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2006 | 2019 |